Unique Alzheimer's Disease Vaccines Show Great Potential in Pre-Clinical Studies

High Titers Are Achieved Through Proprietary Composition

Learn More

Alzheimer’s disease Advax(CpG)

Alzheimer’s disease AdvaxCpG-adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules

Learn More

Capo Therapeutics, Inc.

is focused on the generation of peptide or DNA based epitope vaccines for Alzheimer’s Disease

Learn More

Treatment Horizon

A worldwide quest is under way to find new treatments to stop, slow or even prevent Alzheimer’s.

A Closer Look

Changes in the Brain

Scientists continue to unravel the complex brain changes involved in the onset and progression of Alzheimer’s disease. It seems likely that damage to the brain starts a decade or more before memory and other cognitive problems appear.

Signs and Symptoms

Memory problems are typically one of the first signs of cognitive impairment related to Alzheimer’s disease. Some people with memory problems have a condition called mild cognitive impairment (MCI).

 

What Causes Alzheimer’s?

Scientists don’t yet fully understand what causes Alzheimer’s disease in most people. In people with early-onset Alzheimer’s, a genetic mutation is usually the cause. Late-onset Alzheimer’s arises from a complex series of brain changes that occur over decades.

Diagnosis of Alzheimer’s Disease

Learn More

Treatment of Alzheimer’s Disease

 

Learn More